Retatrutide is a laboratory-manufactured synthetic peptide designed for advanced metabolic research. It functions as a multi-receptor agonist interacting with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, making it a subject of interest in experimental metabolic and endocrine studies.

This peptide has gained significant attention within scientific research communities due to its unique triple-agonist mechanism, allowing investigators to explore complex pathways involved in energy balance, metabolic regulation, and hormonal signalling.

Current scientific literature and preclinical investigations have explored Retatrutide in experimental models related to:

• Metabolic signalling and energy regulation pathways
•  Hormonal receptor interaction studies involving GLP-1, GIP, and glucagon receptors
• Experimental glucose metabolism models
• Appetite regulation signalling pathways
• Energy expenditure and metabolic pathway research

Retatrutide is increasingly utilised by laboratories studying the effects of multi-pathway peptide signalling within controlled research environments.

Intended Use: Product supplied strictly as an investigational research compound. It is not approved by the FDA, TGA, or any regulatory authority for therapeutic, diagnostic, or medicinal use. Not for human or animal consumption.